Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-18-036516

Director sold 10,000 shares at $55.16 ($551,600)

  • Director acquired 10,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

CHESS ROBERT · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2018-06-05 Exercise or conversion : show line 1 in the form +10,000 $14.26 $142,600 284,223 D
2018-06-05 Sale : show line 2 in the form −10,000 $55.16 $551,600 274,223 D
Open-market sales · 10,000 sh · avg $55.16 · $551,600

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2018-06-05 Exercise or conversion : show line 3 in the form Stock Option −10,000 0 D
Loading xslF345X03/doc4.xml…